Literature DB >> 30258013

Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.

Wangheng Hou1,2, Ruth Cruz-Cosme1, Fayuan Wen1, Jin-Hyun Ahn3, Inez Reeves4, Min-Hua Luo5, Qiyi Tang6.   

Abstract

To countermeasure the host cellular intrinsic defense, cytomegalovirus (CMV) and herpes simplex viruses (HSV) have evolved the ability to disperse nuclear domain 10 (ND10, aka PML body). However, mechanisms underlying their action on ND10 differ. HSV infection produces ICP0, which degrades the ND10-forming protein PML. Human CMV (HCMV) infection expresses IE1 that deSUMOylates PML to result in dispersion of ND10. It has been demonstrated that HSV ICP0 degraded only the SUMOylated PML, so we hypothesized that HCMV IE1 can protect PML from degradation by ICP0. HCMV IE1-expressing cell lines (U-251 MG-IE1 and HELF-IE1) were used for infection of HSV-1 or transfection of ICP0-expressing plasmid. Multilabeling by immunocytochemistry assay and protein examination by Western blot assay were performed to determine the resultant fate of PML caused by ICP0 in the presence or absence of HCMV IE1. Here, we report that deSUMOylation of human PML (hPML) by HCMV IE1 was incomplete, as mono-SUMOylated PML remained in the IE1-expressing cells, which is consistent with the report by E. M. Schilling, M. Scherer, N. Reuter, J. Schweininger, et al. (J Virol 91:e02049-16, 2017, https://doi.org/10.1128/JVI.02049-16). As expected, we found that IE1 protected PML from degradation by ICP0 or HSV-1 infection. An in vitro study found that IE1 with mutation of L174P failed to deSUMOylate PML and did not protect PML from degradation by ICP0; hence, we conclude that the deSUMOylation of PML is important for IE1 to protect PML from degradation by ICP0. In addition, we revealed that murine CMV failed to deSUMOylate and to protect the HSV-mediated degradation of hPML, and that HCMV failed to deSUMOylate and protect the HSV-mediated degradation of mouse PML. However, IE1-expressing cells did not enhance wild-type HSV-1 replication but significantly increased ICP0-defective HSV-1 replication at a low multiplicity of infection. Therefore, our results uncovered a host-virus functional interaction at the posttranslational level.IMPORTANCE Our finding that HCMV IE1 protected hPML from degradation by HSV ICP0 is important, because the PML body (aka ND10) is believed to be the first line of host intrinsic defense against herpesviral infection. How the infected viruses overcome the nuclear defensive structure (PML body) has not been fully understood. Herpesviral proteins, ICP0 of HSV and IE1 of CMV, have been identified to interact with PML. Here, we report that HCMV IE1 incompletely deSUMOylated PML, resulting in the mono-SUMOylated PML, which is consistent with the report of Schilling et al. (J Virol 91:e02049-16, 2017, https://doi.org/10.1128/JVI.02049-16). The mono-SUMOylated PML was subjected to degradation by HSV ICP0. However, it was protected by IE1 from degradation by ICP0 or HSV-1 infection. In contrast, IE1 with L174P mutation lost the function of deSUMOylating PML and failed to protect the degradation of the mono-SUMOylated PML. Whether the mono-SUMOylated PML has any defensive function against viral infection will be further investigated.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HSV-1; SUMOylation; cytomegalovirus (CMV); herpes simplex virus (HSV); immediate-early protein 1 (IE1); infected cellular protein (ICP0); nuclear domain 10 (ND10); promyelocytic leukemia protein (PML)

Mesh:

Substances:

Year:  2018        PMID: 30258013      PMCID: PMC6232464          DOI: 10.1128/JVI.01452-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms.

Authors:  M Fagioli; M Alcalay; P P Pandolfi; L Venturini; A Mencarelli; A Simeone; D Acampora; F Grignani; P G Pelicci
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

2.  Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein.

Authors:  Heejung Kang; Eui Tae Kim; Hye-Ra Lee; Jung-Jin Park; Yoon Young Go; Cheol Yong Choi; Jin-Hyun Ahn
Journal:  J Gen Virol       Date:  2006-08       Impact factor: 3.891

3.  Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.

Authors:  Nina Tavalai; Peer Papior; Sabine Rechter; Martina Leis; Thomas Stamminger
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein.

Authors:  A de Bruyn Kops; D M Knipe
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

Review 5.  Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.

Authors:  G G Maul; D Negorev; P Bell; A M Ishov
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

6.  The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.

Authors:  Eva-Maria Schilling; Myriam Scherer; Nina Reuter; Johannes Schweininger; Yves A Muller; Thomas Stamminger
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

7.  PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.

Authors:  Chris Boutell; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments.

Authors:  Myriam Scherer; Nina Reuter; Nadine Wagenknecht; Victoria Otto; Heinrich Sticht; Thomas Stamminger
Journal:  J Gen Virol       Date:  2013-02-13       Impact factor: 3.891

9.  Murine cytomegalovirus major immediate-early protein 3 interacts with cellular and viral proteins in viral DNA replication compartments and is important for early gene activation.

Authors:  Francisco Puerta Martínez; Ruth S Cruz Cosme; Qiyi Tang
Journal:  J Gen Virol       Date:  2010-07-14       Impact factor: 3.891

10.  Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Authors:  V Lallemand-Breitenbach; J Zhu; F Puvion; M Koken; N Honoré; A Doubeikovsky; E Duprez; P P Pandolfi; E Puvion; P Freemont; H de Thé
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  2 in total

1.  Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.

Authors:  Christina Paulus; Thomas Harwardt; Bernadette Walter; Andrea Marxreiter; Marion Zenger; Edith Reuschel; Michael M Nevels
Journal:  PLoS Pathog       Date:  2020-05-04       Impact factor: 6.823

Review 2.  Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.

Authors:  Catherine S Adamson; Michael M Nevels
Journal:  Viruses       Date:  2020-01-16       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.